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SUMMARY
Malaria in malaria-na€ıve adults is associated with an
inflammatory response characterized by expression of speci-
fic activation markers on innate immune cells. Here, we
investigate activation and adhesion marker expression, and
cytokine production in monocytes from children presenting
with cerebral malaria (CM, n = 36), severe malarial anae-
mia (SMA, n = 42) or uncomplicated malaria (UM,
n = 66), and healthy aparasitemic children (n = 52) in
Blantyre, Malawi. In all malaria groups, but particularly in
the two severe malaria groups, monocyte expression of
CD11b, CD11c, CD18, HLA-DR and CD86, and percent-
ages of TNF-a- and IL-6-producing monocytes were lower
than in healthy controls, while expression of CD11a, TLR2
and TLR4 was lower in children with severe malaria com-
pared with controls. These levels mostly normalized during
convalescence, but percentages of cytokine-producing mono-
cytes remained suppressed in children with SMA. In all
malaria groups, especially the SMA group, a greater propor-
tion of monocytes were loaded with haemozoin than among
controls. In a P. falciparum hyperendemic area, monocytes
in children with acute symptomatic malaria have reduced
expression of adhesion molecules and activation markers
and reduced inflammatory cytokine production. This
immune suppression could be due to accumulation of haemo-
zoin and/or previous exposure to P. falciparum.
Keywords integrins, monocytes, toll-like receptors and
cytokines
INTRODUCTION
The acquisition of protective immunity against malaria
requires repeated infections over a number of years (1).
Particularly, during the early stages of a malaria infection,
innate immunity, involving monocytes and other immune
cells, plays a crucial role in controlling parasite growth
rate (2). Monocytes are precursors of macrophages and
dendritic cells. Their main functions are phagocytosis,
antigen presentation and cytokine production (3). Pro-
inflammatory cytokines, such as TNF-a and IL-6 which
are produced by monocytes among other cells, are elevated
in severe malaria and appear to be important for control-
ling infection (4). However, their excessive production has
been linked to immunopathogenesis in malaria (5, 6).
Also implicated in immunity and pathogenesis of
malaria are the adhesion molecules which are particularly
important in the sequestration of parasitized red blood
cells to vascular endothelium (7). During inflammation,
upregulation of adhesion molecule expression serves to
enhance cell-to-cell interactions and transmission of sig-
nals that direct effector functions. The major adhesion
molecule families involved in leucocyte trafficking, activa-
tion and differentiation are the integrins, selectins (L-selec-
tin, E-selectin, and P-selectin) and immunoglobulin super-
family members (8).
The integrins are a large family of ab-heterodimers.
Integrins incorporating b2 (CD18) are restricted to leuco-
cytes and all are expressed on monocytes. CD11a, b and c
all combine with CD18 to form different integrins. They
bind a variety of ligands including ICAM-1 and ICAM-2
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which are expressed by endothelial cells. Endothelial
ICAM-1 is a key factor in cytoadherence of malaria-para-
sitized red blood cells (9).
HLA-DR and CD86 are expressed on monocytes and
serve as activation markers. While HLA-DR is critical for
cognate interactions associated with peptide presentation
to ab-CD4+ T cells, CD86 is key for accessory signalling
(10). Monocytes also express Toll-like receptors (TLRs)
which are pattern-recognition receptors (PRRs) that recog-
nize pathogen-associated molecular patterns (PAMPs)
including microbial pathogens, virulence factors and intra-
cellular protozoan parasites (11). TLRs are involved in the
initial activation of the innate immune system (12) and are
capable of recognizing a wide range of microbial compo-
nents including bacterial lipopolysaccharides (LPS),
lipopeptides, and glycolipids, unmethylated bacterial DNA
and viral nucleic acids (11).
P. falciparum-derived glycosylphosphatidylinositol (GPI)
is known to induce potent TNF-a responses in macro-
phages (13). Recognition of these membrane components
from P. falciparum is mediated by TLR-2, and to a lesser
extent, TLR-4 (14) and microparticles produced by
infected red blood cells are also known to induce immune
responses through the recognition of TLR-4 (15). TLR-9,
expressed particularly in either dendritic cells or B cells,
but also at low levels on monocytes, T cells and NK cells
(16), recognizes P. falciparum haemozoin (17), with DNA
bound to proteins or nucleosomes being the true parasite
ligand for TLR-9 (16,18–20). TLR and other immune sig-
nalling pathways may be subject to downregulation follow-
ing stimulation. Before the discovery of TLRs, it was
known that stimulation with endotoxin (lipopolysaccha-
ride, LPS), now known to be the major ligand of TLR-4,
induces tolerance to restimulation, both in vitro and
in vivo (21).
During the intraerythrocytic life cycle of P. falciparum,
haemoglobin is degraded but the parasite is unable to
catabolize haem, which aggregates forming an insoluble
polymer called malarial pigment or haemozoin (22). Neu-
trophils, monocytes and resident macrophages ingest
haemozoin and haemozoin-containing parasitized erythro-
cytes. Phagocytosis of haemozoin by monocytes has been
shown to have both stimulatory effects, including induc-
tion of pro-inflammatory cytokines (23), and inhibitory
effects, including reduced phagocytosis and oxidative burst
(24), and reduced expression of CD11c (25).
We conducted this study to explore expression of
CD11a, CD11b, CD11c, CD18, HLA-DR, CD86, TLR-2
and TLR-4 and production of TNF-a and IL-6 by mono-
cytes in Malawian children presenting with different clini-
cal forms of malaria.
MATERIALS AND METHODS
Study population
For the first study, participants were children admitted
with malaria to Queen Elizabeth Central Hospital
(QECH), and medically well children attending surgical
outpatient clinics at QECH and Beit Cure International
Hospital, both in Blantyre. Demographic and clinical fea-
tures of the participants have been reported before (26). In
brief, children were enrolled during the rainy season
(November 2005 to April 2006) after obtaining informed
consent from the parent or guardian. Each child was
examined by a research nurse and/or clinical officer, base-
line demographic data were recorded, and a peripheral
blood sample was collected.
The children were assessed for level of consciousness
using the Blantyre Coma Score (BCS) on admission and
during intensive clinical care. Over forty children were
prospectively enrolled into each of the four clinical groups
defined by diagnoses of CM, SMA, UM or healthy con-
trols (Table S1). Malaria was defined as a clinical syn-
drome without an apparent alternative cause, in the
presence of P. falciparum asexual parasites on blood film
microscopy.
Children presenting with CM had a BCS of 2/5 or less
at admission and 4 h later, while children in all other
groups had a score of 5/5 at both times. Those presenting
with SMA had a blood haemoglobin concentration of 5 g/
dL or less, and all other children had a haemoglobin con-
centration above this level. Children who tested positive
for HIV infection were excluded from the study and were
referred to the antiretroviral therapy clinic.
Expression of surface markers on peripheral blood
monocytes and proportion of haemozoin-loaded
monocytes were investigated. Following exclusions, 113
children with malaria (54 with UM, 30 with SMA, 29
with CM) and 42 healthy controls were recruited. Of
the children with malaria, 73 (34 UM, 21 SMA and 18
CM) were successfully followed up a month after treat-
ment.
For the second study, a further set of 41 children were
recruited from November 2006 to February 2007 from the
same health centres as the first set (Table S2) and using
the same criteria: 12 with UM, 12 with SMA, 7 with CM
and 10 healthy controls. Percentages of TNF-a- and IL-6-
producing monocytes were determined. Fourteen of thirty-
one (45%) children with malaria (6 UM, 4 SMA and 4
CM) were aparasitaemic when followed up a month after
treatment. Convalescence data were only collected from
well and aparasitaemic children.
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Ethics review and approval
Ethical approval for the study was obtained from College
of Medicine Research and Ethics Committee (COMREC)
and Ethics Committee of the Liverpool School of Tropical
Medicine, UK. Written informed consent was obtained
from the parent or guardian of every child before the child
was recruited into the study. A 5-mL venous blood sample
was taken at the time of recruitment and in convalescence.
Blood was collected in EDTA anticoagulant for
immunophenotyping and heparin for cytokine production.
HIV, malaria parasite and haemozoin tests
HIV testing was performed using two rapid tests; Determine
HIV1/HIV2 (Abbott Laboratories, Japan) and Unigold
(Trinity Biotech, Dublin), according to the manufacturers’
instructions. Malaria parasitaemia was determined by thick
and thin blood films. Reading of the slides for malaria para-
sites and for haemozoin (performed for the first group only)
was according to standard procedures (27).
Immunophenotyping
For each sample, 25 lL of EDTA blood was mixed with
1 lL of three directly conjugated antibodies: a FITC-con-
jugated antibody (anti-CD11a, anti-CD18, anti-HLA-DR,
anti-CD86), a PE-conjugated antibody (anti-CD11b, anti-
CD11c, anti-TLR-2, anti-TLR-4) and anti-CD14-APC.
Samples were incubated for 15 min in the dark at room
temperature. About 500 lL of 19 FACS lysing solution
(Becton Dickinson, Franklin Lakes, NJ, USA) was added
to each tube and incubated in the dark for 10 min at
room temperature. Cells were washed twice with 2 mL of
PBS and fixed with 100 lL PBS/1% formaldehyde. Data
were acquired on a BD FACSCalibur flow cytometer and
analysed using CELLQUEST PRO software (San Jose, CA,
USA) as shown in Figure 4.
Detection of TNF-a- and IL-6-producing monocytes by
flow cytometry
An aliquot of 1 mL of heparin blood was mixed with 10 lL
of 100 lg/mL LPS and 10 lL of 1 lg/mL Brefeldin A
(BFA). The mixture was vortexed and incubated at 37°C, 5%
CO2 for 4 h in loose-capped tubes. A negative control, con-
taining 1 mL of blood from the same patient but without any
LPS added, was also vortexed and incubated under the same
condition. An aliquot of 50 lL of stimulated and unstimu-
lated blood was labelled with 2 lL of anti-CD14-APC and
incubated in the dark at room temperature for 15 min. 2 mL
of 19 FACS lysis solution was added to each tube, vortexed
and incubated in the dark for 10 min. Tubeswere centrifuged
at 1600 rpm and 4°C for 5 min, the supernatant aspirated
and 500 lL of 19 FACS Perm (Becton Dickinson) added to
each tube which was then incubated in the dark for 10 min.
Cells were then washedwith 2 mL of PBS/05% bovine serum
albumin (BSA). Four microlitres of PE-conjugated anti-
TNF-a or anti-IL-6 was added to each tube. Each tube was
vortexed and incubated for 30 min in the dark at room tem-
perature, washed with 2 mL of PBS/05% BSA and the cells
fixed with 200 lL PBS/1% formaldehyde. Data were
acquired and analysed on a FACSCalibur instrument within
an hour. We monitored the calibration of our flow cytometer
a minimum of once per week using CALIBRITE BEADS and FAS-
COMP software (both Becton Dickinson).
Data were analysed using CELL QUEST software (Becton
Dickinson). The gating procedure was conducted as shown
in Fig. 1. Samples were gated on monocytes by side scat-
tered light and CD14 expression. Results were expressed
as the percentage of cytokine-producing cells in the
CD14+ cell population. The following formula was used
for calculating the percentage of cytokine-producing
monocytes:
½%CD14þcytokineþðSÞ %CD14þisotypeþðSÞ
 ½%CD14þcytokineþðUÞ  CD14þisotypeþðUÞ:
(S = stimulated and U = unstimulated cell cultures).
Data analysis
Statistical tests were performed using GRAPHPAD PRISM ver-
sion 6.01 for Windows (GraphPad Software, San Diego
California USA). A P value of <005 was considered sta-
tistically significant at 95% level of confidence. The
Kruskal–Wallis test was used to compare the geometric
mean fluorescent intensity (GMFI) values for the markers
CD11a, CD11b, CD11c, CD18, TLR-2, TLR-4, HLA-DR
and CD86 on monocytes, the percentage of TNF-a- and
IL-6-producing monocytes and the percentage of haemo-
zoin-loaded monocytes in different clinical groups. Wil-
coxon-matched pairs test was used to determine the
statistical significance of the differences in GMFI values
or percentage of cytokine-producing monocytes observed
during acute infection and in convalescence for each clini-
cal type of malaria.
RESULTS
Clinical malaria is characterized by low expression of
integrins on monocytes
During acute malaria, the mean expression levels of inte-
grins CD11a, CD11b, CD11c and CD18 were significantly
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lower than in controls for each clinical form of malaria,
with the exception of CD11a in UM (Fig. 2a–d). Integrin
expression levels significantly recovered in convalescence,
except for CD11b expression, which only increased in chil-
dren with SMA, and CD11c, which decreased in convales-
cence among children with UM (Fig. 2a–d).
Clinical malaria is characterized by low expression of
TLRs, HLA-DR and CD86 on monocytes
Mean expression of TLR-2 and TLR-4 was significantly
lower in children with acute CM and SMA compared with
healthy controls (Fig. 2e,f), while HLA-DR and CD86
expression was significantly lower in all three malaria
groups (Fig. 2g,h). In convalescence, the expression of
TLR-2 and TLR-4 was lower in all three clinical forms of
malaria compared to levels observed in acute disease, but
this difference was only significant in the UM group. In
contrast, expression of CD86 increased significantly in
convalescence in all malaria groups and the expression
was similar to those observed in healthy controls (Fig. 3h).
Although the expression of HLA-DR in convalescence of
all three clinical malaria types was significantly higher
than that observed in acute disease, the convalescence
expression levels were still lower, though not significantly,
than those observed in healthy controls (Fig. 3g).
Acute malaria is characterized by a low proportion of
TNF-a- and IL-6-producing monocytes
During acute malaria, percentages of TNF-a- and
IL-6-producing monocytes in all clinical groups were sig-
nificantly lower than in controls (Fig. 5a,b), with children
with CM having the lowest percentage. In convalescence,
there was a marked recovery of TNF-a- and IL-6-produ-
cing monocytes in children with CM, but for those with
SMA, the percentage remained low.
High percentages of monocytes are loaded with
haemozoin in SMA compared with other forms of
malaria
In all forms of malaria, haemozoin was visible in a pro-
portion of circulating monocytes by light microscopy
(a) (b) (c) Figure 1 Gating strategy for determining the
monocyte population in the side-scatter/
CD14 plot (a) the proportion of TNF-
alpha-producing (b) and IL-6-producing (c)
monocytes.
Control UCM SMA CM
0
5
10
15
20
25 **
*
C
D
11
a+
 G
M
FI
Control UCM SMA CM
0
50
100
150
200
250 *
***
**
C
D
11
b+
 G
M
FI
Control UCM SMA CM
0
50
100
150
200 ***
***
***
C
D
11
c+
 G
M
FI
Control UCM SMA CM
0
10
20
30
40 ***
***
*
C
D
18
+C
D
14
+ 
G
M
FI
Control UCM SMA CM
0
5
10
15 **
***
TL
R
-2
+ 
G
M
FI
Control UCM SMA CM
0
1
2
3
4
*
TL
R
-4
+ 
G
M
FI
*
Control UCM SMA CM
0
10
20
30
40 ***
***
***
H
LA
-D
R
+ 
G
M
FI
Control UCM SMA CM
0
1
2
3
4
5 ***
***
*
C
D
86
+ 
G
M
FI
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 2 (a to h): Medians (10th and 90th percentiles) of geometric mean florescence intensity (GMFI) of CD11a (a), CD11b (b), CD11c
(c), CD18 (d), TLR-2 (e), TLR-4 (f), HLA-DR (g) and CD86 (h) expressions on monocytes from children presenting with UCM, SMA
and CM, compared to monocytes from healthy aparasitaemic children. ***P < 00001, **P < 0001, *P < 005.
320 © 2016 The Authors. Parasite Immunology Published by John Wiley & Sons Ltd., Parasite Immunology, 38, 317–325
W. L. Mandala et al. Parasite Immunology
(Table S1). Children with SMA had a higher median per-
centage of haemozoin-loaded monocytes (175%) com-
pared with those with CM (100%; P = 003) and UM
(40%; P < 001).
DISCUSSION
We analysed the expression of different activation and
adhesion markers and percentages of cytokine-producing
monocytes in Malawian children presenting with different
clinical forms of P. falciparum malaria. Expression of most
integrins and adhesion markers was reduced significantly
during acute malaria especially in children presenting with
acute SMA and CM who had the highest proportion of
haemozoin-loaded monocytes, when compared with con-
trols or convalescent levels. Proportions of cytokine-produ-
cing monocytes were also reduced in acute infection of all
clinical types of malaria, with the lowest percentages
observed for children with CM. Most results normalized
in convalescence with the notable exception of pro-
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
10
20
30
*****
C
D
11
a+
 G
M
FI
*
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
50
100
150
200
250
***
C
D
11
b+
 G
M
FI
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
50
100
150
200 ******
C
D
11
c+
 G
M
FI
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
10
20
30
40
******
*
C
D
18
+ 
G
M
FI
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
5
10
15 ***
TL
R
-2
+ 
G
M
FI
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
1
2
3
4
***
TL
R
-4
+ 
G
M
FI
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
10
20
30
40 ******
***
H
LA
-D
R
+ 
G
M
FI
C
on
tr
ol
U
C
M
U
C
M
-F
SM
A
SM
A
-F C
M
C
M
-F
0
2
4
6
***
******
C
D
86
+ 
G
M
FI
(a) (b) (c) (d)
(e) (f) (g) (h)
Figure 3 (a to h): Medians (10th and 90th percentiles) of geometric mean florescence intensity (GMFI) of CD11a (a), CD11b (b), CD11c
(c), CD18 (d), TLR-2 (e), TLR-4 (f), HLA-DR (g) and CD86 (h) expression on monocytes in children acute malaria (UCM, SMA and
CM) and at follow-up during convalescence (UCM-F, SMA-F and CM-F), compared with monocytes from healthy aparasitaemic children.
***P < 00001, **P < 0001, *P < 005.
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Figure 4 Gating strategy for determining the monocyte population in the side-scatter/CD14 plot (a), the geometric mean fluorescent
intensity (GMFI) values for monocyte surface markers CD11a (b), CD11b (c), CD11c (d), CD18 (e), activation marker HLR-DR (f), Toll-
like receptor 2 (g), activation marker CD86 (h) and TLR-4 (i) expressed on monocytes. The grey histograms represent the GMFI of the
isotype controls, and the white histogram represents the GMFI of the different surface and activation markers.
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inflammatory cytokine-producing cells in SMA, and TLR-
2 and TLR-4 expression during convalescence from all
forms of malaria. In all patient groups, a higher propor-
tion of monocytes were loaded with haemozoin than in
controls.
Clinical malaria has been characterized by the presence
of highly activated circulating T-cell subsets in a number
of studies (5, 28–31), and we have previously reported the
same finding among children in the present study (26).
This is consistent with the concept that stimulation of
immune effector cells by products from malaria infection
results in the release of pro-inflammatory cytokines
responsible for clearing parasites from the circulation (5,
30). Our finding of low expression of integrins, TLRs and
activation markers HLA-DR and CD86, on monocytes
during acute malaria, is indicative of a contrasting
immunosuppressive effect. However, unlike in the case of
TLRs, in which the expression is even lower in convales-
cence, the expression of the activation markers HLA-DR
and CD86 is higher in convalescence compared to the
expression in acute disease, suggesting that the activation
markers recover faster from immunosuppressive effect that
the integrins.
Ingestion of haemozoin could well be the underlying
reason for our observations in monocytes. As mentioned,
haemozoin is a product of malaria infection that accumu-
lates in phagocytic cells, including monocytes, and has
been implicated in both stimulatory and inhibitory
immunological effects (23). These differential effects are
likely to be dependent on the time course of exposure to
haemozoin and could vary depending on prior malaria
exposure and in vitro compared with in vivo exposure.
Expression of MHC class II (HLA-DP, HLA-DQ and
HLA-DR) and CD11c, but not CD11b, has been shown
to decrease in monocytes in vitro 48 h following phagocy-
tosis of haemozoin (25). In contrast, in another study with
a 2 h time course, in vitro exposure of leucocytes to
isolated malaria pigment from ruptured schizonts resulted
in upregulation of CD11b/CD18 on monocytes. The earli-
est response detected 10 min after exposure to malaria
pigment, with a plateau reached at 60 min, followed by a
decline at 90 min (32). Both studies were conducted on
blood collected from na€ıve nonexposed adults.
The global low expression of all surface markers exam-
ined in the present study, including CD11a, CD11b,
CD11c and CD18, could be due to the much longer time
course involved. Using samples from children with clinical
malaria, monocytes are exposed to malaria-parasitized red
cells and haemozoin for several days prior to the develop-
ment of clinical symptoms and presentation at hospital. In
addition, prior exposure to P. falciparum could prime the
immunosuppressive effects observed. In contrast, expres-
sion of CD11a/CD18 on lymphocytes has been shown to
increase in Sudanese children with uncomplicated malaria
(33). This could be because, unlike monocytes, lympho-
cytes do not accumulate haemozoin.
The marked depression of TLR-2 compared with TLR-
4 expression in acute severe malaria (CM and SMA) could
be the result of downregulation of TLR-2 secondary to
binding by P. falciparum GPI (14, 34). Low expression of
TLR-2, TLR-4 and CD86 in acute SMA and CM is con-
sistent with the results of a study (35) assessing the effect
of P. falciparum macrophage migration inhibitory factor
(PfMIF) on monocyte function. This indicates another
possible mechanism of monocyte immune suppression to
account for our findings. PfMIF is released during malaria
and appears to modulate monocyte function, suppressing
signalling through TLRs.
In contrast with our findings, Thai adults with severe and
mild malaria had raised monocyte TLR-2 expression, com-
pared with controls, but there was no significant difference
in TLR-4 expression (36). In another study, expression of
TLR-2 or TLR-4 on monocytes from malaria-na€ıve volun-
teers did not change significantly following 24 h of in vitro
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Figure 5 (a to b): Medians (10th and 90th percentiles) of percentage of TNF-a- (a) and IL-6-producing monocytes (b) in children
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stimulation with P. falciparum lysate (37). In a recent study
of P. falciparum malaria infection in malaria-na€ıve volun-
teers, monocyte HLA-DR and CD86 expressions were
increased at the time when parasitaemia was detected on
thick blood film, prior to drug treatment (38).
All three studies involved clinical material from adults
who were na€ıve to malaria, in contrast to our study among
African children with malaria in a P. falciparum hyperen-
demic area. Repeated prior exposure to P. falciparum in
our age group and setting may account for these reported
differences in TLR expression. Immune signalling path-
ways, including those involving TLRs, are subject to mod-
ulation by various mechanisms, most commonly
downregulation following stimulation. Stimulation with
lipopolysaccharide, the main TLR-4 ligand, induces toler-
ance to restimulation (39). Thus, the observation that the
expression of both TLR-2 and TLR-4 in convalescence of
all malaria types was even lower than that observed in
acute infection could be a result of such tolerance which
could take longer than 30 days to dissipate.
The low frequencies of TNF-a- and IL-6-producing
monocytes in children with malaria in our study contrast
with the presence of activated lymphocyte subsets in
malaria with high expression of CD69 (26, 28). It is likely
that these monocytes were already anergic and refractory
to further stimuli when stimulated in vitro. Ingestion of
haemozoin by monocytes over several days may well have
contributed to this refractory state. This is in contrast
to enhanced TNF-a production by monocytes following
1–2 h in vitro stimulation with haemozoin (39).
Notably, the fraction of TNF-a- and IL-6-producing
monocytes in CM was lower than in SMA. One month
into convalescence, the percentages in CM children had
recovered and were the same as present in controls. In
contrast, these percentages were still low in convalescent
children with SMA. This sustained suppression of inflam-
matory cytokine production among children with SMA
may contribute to the increased susceptibility of such chil-
dren to bacteraemia with nontyphoidal strains of Sal-
monella (40). Inflammatory Th1 cytokines, including
TNF-a, are important for protection against nontyphoidal
Salmonella (41, 42). While the clinical association between
invasive nontyphoidal Salmonella disease and malaria has
been known for a long time (43), this association is most
evident in SMA compared with other forms of malaria
(44).
Our findings support the concept of immune suppres-
sion of monocyte function among African children with
malaria, and this may be secondary to phagocytosis of
haemozoin. The findings also indicate that monocyte char-
acteristics following exposure to malaria differ depending
on the population studied, transmission intensity, prior
exposure to P. falciparum, patient age and clinical form of
malaria. Factors that affect monocyte haemozoin content
and length of exposure to haemozoin may account for
these differences.
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